Food-effect Bioavailability of Gemigliptin and Dapagliflozin 50/10 mg
Status:
Not yet recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
A Randomized, Open-label, Single-dose, Two-way Crossover Study to Investigate Food-effect
Bioavailability of Gemigliptin and Dapagliflozin 50/10 mg Fixed Dose Combination Film-coated
Tablet under Fed and Fasting Conditions in Healthy Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
LG Chem
Treatments:
Dapagliflozin Dipeptidyl-Peptidase IV Inhibitors Sodium-Glucose Transporter 2 Inhibitors